AI, Coaching and New Therapy Option to Quell 2.0
The smart wearable harnessing the power of neurostimulation and AI to attack the chronic pain crisis.
NeuroMetrix Inc. (Nasdaq: NURO) today unveiled its smartest, smallest and most powerful wearable therapeutic to date. With new features seen for the first time at CES, the recently launched Quell® 2.0 is 50% smaller, yet 20% more powerful than its predecessor. The Company will introduce new functionality at CES that includes updates to the Quell app like coaching that helps users achieve the best possible outcomes. It also takes Pain Tech to a new level with an “Intensive Therapy” option and is the first wearable technology to utilize machine learning to deliver unprecedented personalization for the treatment of chronic pain.
Named a CES® 2019 Innovation Awards Honoree, in the Fitness, Sports and Biotech product category, Quell is a 100% drug-free system that uses prescription strength nerve-stimulation technology to block chronic pain. Aspiring to be part of the solution to the chronic pain crisis, Quell is designed for multiple types and sources of pain and has been shown in clinical studies to relieve chronic pain. It can be seen during CES January 8-11, 2019 at the Sands Expo Center, Hall C Booth #43810.
How It Works
A Class II medical device, Quell® 2.0 is an advanced form of transcutaneous electrical nerve stimulation (TENS). The device is worn on the leg, regardless of the site of pain, and sends neural pulses to the brain that trigger a natural pain relief response in the central nervous system.
Worn in a breathable soft, flexible band, the Quell device has a credit card sized footprint so that it is discreet and comfortable under clothing. Quell 2.0 is powered by a proprietary neurostimulation microchip. It is 50% smaller than the original Quell device, yet it outputs up to 20% more electrical power. Quell technology is up to 10x more powerful than typical OTC TENS devices.*
We're here for you.or call 800.204.6577